Vincristine-induced peripheral neuropathy in pediatric cancer patients
about
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisA Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.New model of vincristine-induced neuropathic pain in children: a first step towards prediction and prevention.A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain.
P2860
Vincristine-induced peripheral neuropathy in pediatric cancer patients
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@ast
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@en
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@nl
type
label
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@ast
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@en
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@nl
prefLabel
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@ast
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@en
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@nl
P2093
P2860
P1476
Vincristine-induced peripheral neuropathy in pediatric cancer patients
@en
P2093
Daniel L Hertz
Ellen M Lavoie Smith
Erika Mora
P2860
P304
P407
P577
2016-11-01T00:00:00Z